Cross-sectorial Rehabilitation of Patients with Lung Cancer

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Four thousand seven hundred patients are diagnosed with lung cancer in Denmark every year. Even though cigarette smoking has declined for decades a decline in lung cancer incidence is still at least a decade away. Only 16% of these patients with lung cancer started in a municipal rehabilitation program. Aim: To investigate if the intervention early contact conference can facilitate acceptance of and participation in municipal rehabilitation in patients with lung cancer. Further, to investigate whether the rehabilitation improve the patients' physical ability and quality of life. Thirteen municipalities from Region Hovedstaden have agreed to participate in this cluster randomized controlled trial. The intervention will focus on creating early contact between the Department of Oncology and the municipalities. The conference call will be planned when the patient is at the hospital for the second systemic treatment and a written status will be sent to the GP after the conference video call so that hospital, municipality, and GP will all have the newest knowledge about the patient's general condition The intervention will be easy to implement in clinical practice afterwards if it is a success and the cost of the intervention is low.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• patients diagnosed with NSCLC

• 1\. line systemic treatment

Locations
Other Locations
Denmark
Herlev and Gentofte Hospital
RECRUITING
Herlev
Contact Information
Primary
Camilla S Balle, PhD student
camilla.sick.balle@regionh.dk
+45 51332047
Backup
Julia S Johansen, Professor
Julia.Sidenius.Johansen@regionh.dk
+45 38689241
Time Frame
Start Date: 2024-10-07
Estimated Completion Date: 2027-01-01
Participants
Target number of participants: 130
Treatments
Experimental: Intervention group: video conference
No_intervention: No intervention
Related Therapeutic Areas
Sponsors
Leads: Camilla Balle

This content was sourced from clinicaltrials.gov